Warren D. Shlomchik

Warren D. Shlomchik

Auto-generated profile, based on publicly available information

Warren D. Shlomchik

Department of Immunology, University of Pittsburgh, Pittsburgh, United States of America

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2017 in Science Immunology
Verified
Journal Article
Closed access
PDF file
HDHehua Dai
Hehua Dai
AFAndrew J. Friday
Andrew J. Friday
KAKhodor I. Abou-Daya
Khodor I. Abou-Daya
AWAmanda L. Williams
Amanda L. Williams
SMSteven Mortin-Toth
Steven Mortin-Toth
FLFadi G. Lakkis
Fadi G. Lakkis
Mice devoid of T, B, and natural killer (NK) cells distinguish between self and allogeneic nonself despite the absence of an adaptive immune system. When challenged with an allograft, they mount an innate response characterized by accumulation of mature, monocyte-derived dendritic cells (DCs) that produce interleukin-12 and present antigen to T cells. However, the molecular mechanisms by which the innate immune system detects allogeneic nonself to generate these DCs are not known. To address this question, we studied the innate response of Rag2−/−γc−/− mice, which lack T, B, and NK cells, to grafts from allogeneic donors. By positional cloning, we identified that donor polymorphism in the gene encoding signal regulatory protein α (SIRPα) is a key modulator of the recipient’s innate allorecognition response. Donors that differed from the recipient in one or both Sirpa alleles elicited an innate alloresponse. The response was mediated by binding of donor SIRPα to recipient CD47 and was modulated by the strength of the SIRPα-CD47 interaction. Therefore, sensing SIRPα polymorphism by CD47 provides a molecular mechanism by which the innate immune system distinguishes between self and allogeneic nonself independently of T, B, and NK cells.

4 March 2021 in Science Immunology
Verified
Journal Article
Closed access
PDF file
KAKhodor I. Abou-Daya
Khodor I. Abou-Daya
RTRoger Tieu
Roger Tieu
DZDaqiang Zhao
Daqiang Zhao
RRRayan Rammal
Rayan Rammal
FSFaruk Sacirbegovic
Faruk Sacirbegovic
FLFadi G. Lakkis
Fadi G. Lakkis
Tissue-resident memory T cells (TRM) contained at sites of previous infection provide local protection against reinfection. Whether they form and function in organ transplants where cognate antigen persists is unclear. This is a key question in transplantation as T cells are detected long term in allografts, but it is not known whether they are exhausted or are functional memory T cells. Using a mouse model of kidney transplantation, we showed that antigen-specific and polyclonal effector T cells differentiated in the graft into TRM and subsequently caused allograft rejection. TRM identity was established by surface phenotype, transcriptional profile, and inability to recirculate in parabiosis and retransplantation experiments. Graft TRM proliferated locally, produced interferon-γ upon restimulation, and their in vivo depletion attenuated rejection. The vast majority of antigen-specific and polyclonal TRM lacked phenotypic and transcriptional exhaustion markers. Single-cell analysis of graft T cells early and late after transplantation identified a transcriptional program associated with transition to the tissue-resident state that could serve as a platform for the discovery of therapeutic targets. Thus, recipient effector T cells differentiate into functional graft TRM that maintain rejection locally. Targeting these TRM could improve renal transplant outcomes.

14 April 2023 in Science Immunology
Verified
Journal Article
Closed access
RTRoger Tieu
Roger Tieu
QZQiang Zeng
Qiang Zeng
DZDaqiang Zhao
Daqiang Zhao
GZGang Zhang
Gang Zhang
NFNeda Feizi
Neda Feizi
FLFadi G. Lakkis
Fadi G. Lakkis
Our understanding of tissue-resident memory T (T RM ) cell biology has been largely developed from acute infection models in which antigen is cleared and sterilizing immunity is achieved. Less is known about T RM cells in the context of chronic antigen persistence and inflammation. We investigated factors that underlie T RM maintenance in a kidney transplantation model in which T RM cells drive rejection. In contrast to acute infection, we found that T RM cells declined markedly in the absence of cognate antigen, antigen presentation, or antigen sensing by the T cells. Depletion of graft-infiltrating dendritic cells or interruption of antigen presentation after T RM cells were established was sufficient to disrupt T RM maintenance and reduce allograft pathology. Likewise, removal of IL-15 transpresentation or of the IL-15 receptor on T cells during T RM maintenance led to a decline in T RM cells, and IL-15 receptor blockade prevented chronic rejection. Therefore, antigen and IL-15 presented by dendritic cells play nonredundant key roles in CD8 T RM cell maintenance in settings of antigen persistence and inflammation. These findings provide insights that could lead to improved treatment of chronic transplant rejection and autoimmunity.

25 November 2019 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
AHAndrew D. Hughes
Andrew D. Hughes
DZDaqiang Zhao
Daqiang Zhao
HDHehua Dai
Hehua Dai
KAKhodor I. Abou-Daya
Khodor I. Abou-Daya
RTRoger Tieu
Roger Tieu
FLFadi G. Lakkis
Fadi G. Lakkis
Activation of host T cells that mediate allograft rejection is a 2-step process. The first occurs in secondary lymphoid organs where T cells encounter alloantigens presented by host DCs and differentiate to effectors. Antigen presentation at these sites occurs principally via transfer of intact, donor MHC-peptide complexes from graft cells to host DCs (cross-dressing) or by uptake and processing of donor antigens into allopeptides bound to self-MHC molecules (indirect presentation). The second step takes place in the graft, where effector T cells reengage with host DCs before causing rejection. How host DCs present alloantigens to T cells in the graft is not known. Using mouse islet and kidney transplantation models, imaging cytometry, and 2-photon intravital microscopy, we demonstrate extensive cross-dressing of intragraft host DCs with donor MHC-peptide complexes that occurred early after transplantation, whereas host DCs presenting donor antigen via the indirect pathway were rare. Cross-dressed DCs stably engaged TCR-transgenic effector CD8+ T cells that recognized donor antigen and were sufficient for sustaining acute rejection. In the chronic kidney rejection model, cross-dressing declined over time but was still conspicuous 8 weeks after transplantation. We conclude that cross-dressing of host DCs with donor MHC molecules is a major antigen presentation pathway driving effector T cell responses within allografts.

30 January 2023 in Immunity
Verified
Journal Article
Closed access
FSFaruk Sacirbegovic
Faruk Sacirbegovic
MGMatthias Günther
Matthias Günther
AGAlessandro Greco
Alessandro Greco
DZDaqiang Zhao
Daqiang Zhao
XWXi Wang
Xi Wang
WSWarren D. Shlomchik
Warren D. Shlomchik

24 August 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
MZMeng Zhou
Meng Zhou
FSFaruk Sacirbegovic
Faruk Sacirbegovic
KZKai Zhao
Kai Zhao
SRSarah Rosenberger
Sarah Rosenberger
WSWarren D. Shlomchik
Warren D. Shlomchik
In hematopoietic cell transplants, alloreactive T cells mediate the graft-versus-leukemia (GVL) effect. However, leukemia relapse accounts for nearly half of deaths. Understanding GVL failure requires a system in which GVL-inducing T cells can be tracked. We used such a model wherein GVL is exclusively mediated by T cells that recognize the minor histocompatibility antigen H60. Here we report that GVL fails due to insufficient H60 presentation and T cell exhaustion. Leukemia-derived H60 is inefficiently cross-presented whereas direct T cell recognition of leukemia cells intensifies exhaustion. The anti-H60 response is augmented by H60-vaccination, an agonist αCD40 antibody (FGK45), and leukemia apoptosis. T cell exhaustion is marked by inhibitory molecule upregulation and the development of TOX+and CD39−TCF-1+cells. PD-1 blockade diminishes exhaustion and improves GVL, while blockade of Tim-3, TIGIT or LAG3 is ineffective. Of all interventions, FGK45 administration at the time of transplant is the most effective at improving memory and naïve T cell anti-H60 responses and GVL. Our studies define important causes of GVL failure and suggest strategies to overcome them.